34.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TGTX Giù?
Forum
Previsione
Frazionamento azionario
Tg Therapeutics Inc Borsa (TGTX) Ultime notizie
Will TG Therapeutics Inc. stock see insider buyingJuly 2025 Chart Watch & Verified Stock Trade Ideas - Trung tâm Dự báo KTTV quốc gia
Can TG Therapeutics Inc. stock resist market sell offsMarket Activity Recap & Free Daily Entry Point Trade Alerts - newser.com
Market Overview: Will TG Therapeutics Inc. stock outperform Dow Jones indexInflation Watch & Safe Entry Momentum Tips - Trung tâm Dự báo KTTV quốc gia
Jim Cramer on TG Therapeutics: “You Should Buy the Stock” - MSN
TG Therapeutics Inc. stock chart pattern explainedJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - newser.com
How TG Therapeutics Inc. stock compares to industry benchmarksJuly 2025 Closing Moves & Low Risk Investment Opportunities - newser.com
Market reaction to TG Therapeutics Inc.’s recent news2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
Evaluating TG Therapeutics Inc. with trendline analysisTrade Volume Report & Weekly Return Optimization Alerts - newser.com
Is TG Therapeutics Inc. forming a reversal patternAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
What candlestick patterns are forming on TG Therapeutics Inc.July 2025 Recap & AI Based Trade Execution Alerts - newser.com
What dividend safety score for TG Therapeutics Inc. stock2025 Fundamental Recap & Weekly High Return Forecasts - newser.com
Published on: 2025-10-14 02:23:58 - newser.com
Is TG Therapeutics Inc. forming a bottoming baseWeekly Risk Report & Daily Chart Pattern Signals - newser.com
How risky is TG Therapeutics Inc. (NKB2) stock compared to peersMarket Growth Review & Growth-Oriented Investment Plans - newser.com
Published on: 2025-10-13 09:09:08 - newser.com
Published on: 2025-10-13 08:45:12 - newser.com
TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring a 29% Upside in the Biotech Sector - DirectorsTalk Interviews
Is TG Therapeutics Inc. stock bottoming outJuly 2025 Market Mood & High Yield Equity Trading Tips - newser.com
What makes TG Therapeutics Inc. (NKB2) stock appealing to growth investorsMarket Risk Analysis & High Return Stock Watch Alerts - newser.com
Is TG Therapeutics Inc. still worth holding after the dipJuly 2025 Retail & Verified Chart Pattern Trade Signals - newser.com
Is TG Therapeutics Inc. reversing from oversold territoryMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
What indicators show strength in TG Therapeutics Inc.Dividend Hike & Expert Approved Momentum Trade Ideas - newser.com
Analysts Offer Predictions for TG Therapeutics Q3 Earnings - MarketBeat
What analysts say about TG Therapeutics Inc stockEarnings Forecast Updates & Identify Breakout Stocks - earlytimes.in
TG Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo
HC Wainwright Weighs in on TG Therapeutics FY2029 Earnings - MarketBeat
TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN
TGTX Receives 'Buy' Rating from HC Wainwright & Co. with $60 Pri - GuruFocus
TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Significant Growth Potential - DirectorsTalk Interviews
Analyzing TG Therapeutics Inc. with risk reward ratio chartsQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Detecting support and resistance levels for TG Therapeutics Inc.July 2025 Drop Watch & Fast Moving Trade Plans - newser.com
Institutional investors are TG Therapeutics, Inc.'s (NASDAQ:TGTX) biggest bettors and were rewarded after last week's US$176m market cap gain - Yahoo Finance
What TG Therapeutics (TGTX)'s Six-Year BRIUMVI Safety Data Means For Shareholders - Yahoo Finance
A Look at TG Therapeutics (TGTX) Valuation Following Positive Six-Year BRIUMVI Trial Results - Sahm
TG Therapeutics, Inc.'s (NASDAQ:TGTX) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 5.8% Over Last Week - 富途牛牛
Key metrics from TG Therapeutics Inc.’s quarterly dataTrade Volume Summary & Precise Buy Zone Identification - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):